NeoVac

📍 Didcot, United Kingdom🗓 Founded 2021👥 18 employees💰 Last funded Sep 2022
Biotechnology Research🌐 neovac.co.uk
Website LinkedIn
NeoVac is creating revolutionary, unique and proprietary next-generation lipid nanoparticles platform to enable better RNA vaccines and medicines for various diseases. Allowing more people around the world access to better and more potent vaccines, using cutting-edge technology that makes RNA vaccines more transportable, with broader capabilities and fewer side effects. 
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Austria
1
Frequently asked questions
Who invested in NeoVac?
NeoVac has 1 investors on record on gritt.io, including 1 early-stage backers.
When did NeoVac last raise funding?
The most recent investment in NeoVac recorded on gritt.io was in September 2022.
When was NeoVac founded?
NeoVac was founded in 2021.
What industry is NeoVac in?
NeoVac operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NeoVac based?
NeoVac is headquartered in Didcot, United Kingdom.